摘要
肺癌是当今世界上严重威胁人类生命与健康的恶性肿瘤性疾病之一，每年有超过100万人死于肺癌。其发病率和病死率逐年增高，引起了越来越多研究者的关注。其中，非小细胞肺癌占肺癌总数的80％～85％。肺癌的分子靶向治疗成为新近研究的热点，是21世纪肺癌治疗最具希望的方法和策略，让人们看到了曙光。
Lung cancer is one of the most serious malignant diseases in the world. More than one million people die from lung cancer each year. And the mortality and morbidity of lung cancer are increasing year by year,which attracts the great attention of a number of researchers. Non-small cell lung cancer accounts for 80% to 85% of the total number of lung cancer. In recent years, molecular targeted therapy has become a focus of study for non-small cell lung cancer. This therapy is the most promising method and strategy of the treatment of lung cancer in the 21st century.
出处
《国际呼吸杂志》
2013年第2期144-148,共5页
International Journal of Respiration
关键词
非小细胞肺癌
分子靶向治疗
Non-small cell lung cancer
Molecular targeted therapy
